CSBR CHAMPIONS ONCOLOGY, INC. — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$5.84

Period return

-0.22 (-3.63%)

Volume

9.8K

2026-06-01O $5.75 H $5.84 L $5.66 C $5.84MA5 $5.88MA20 $6MA60 $5.95MA120 $6.29

6M · 124 barsYahoo Finance · USD2025-12-02 → 2026-06-01

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2025. 03. 12.LowBUYlast year
Craig-Hallum: Buy
US analyst rating / recommendation change.
2024. 12. 13.LowBUYlast year
Craig-Hallum: Buy
US analyst rating / recommendation change.
2024. 09. 12.MediumBUY2 years ago
Craig-Hallum: Buy
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Rating & price-target changes

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Sector: Healthcare
Industry: Biotechnology
HQ: Hackensack, NJ, United States
Fiscal year end: —
Employees: 213
IPO date: —

View details →

2024. 03. 13.MediumHOLD2 years ago

Craig-Hallum: Hold